atrial fibrillation

The Challenge: How to Detect and Diagnose Afib to Prevent Stroke?

A Confusing Condition The cause of AFib is not yet fully understood, even by the world's top scientists and doctors.

The concept is fantastic, not just for AFib, but for patients that come in with (heart) palpitations that are hard to quantify," he said.

2]-microglobulin ATTR Transthyretin AFib Fibrinogen A a-chain AApoAI Apolipoprotein AI AApoAII Apolipoprotein AII ALys Lysozyme AGel Gelsolin ACys Cystatin C Amyloid Protein Syndrome AL/AH Multiple myeloma/plasma cell dyscrasia-associated, also known as primary AA Sporadic: secondary; familial: periodic fevers (b) (familial Mediterranean fever, other) ALect 2 Renal-nephrotic syndrome and/or liver-chronic hepatitisc A[[beta].

This new device has the potential to make AFib ablation more reliable, more reproducible, and more consistent for patients with paroxysmal [intermittent] atrial fibrillation.

David's Medical Center offers a full range of electrophysiology procedures, including catheter ablation--for which physicians utilize the only FDA-approved catheter for treating AFIB, the NAVISTAR THERMOCOOL Irrigated Ablation Catheter.

The 4WARD Coalition and ACT Initiative highlight Boehringer Ingelheim's ongoing commitment to improving the quality of care for AFib patients and investing in addressing the unmet needs of the broader AFib community," said Paul Fonteyne, president and chief executive officer, Boehringer Ingelheim Pharmaceuticals, Inc.

This bi-directional, double balloon catheter enables physicians to rapidly isolate all four pulmonary veins for the treatment of AFib.

In addition, people over the age of 40 have a one in four chance of developing afib in their lifetime.

The study found that, compared to treatment with antiarrhythmic drugs, radiofrequency catheter ablation significantly extended the time to first recurrence of AFib, atrial tachyarrhythmia, atrial flutter and asymptomatic AFib, in patients with paroxysmal recurrent AFib who had not been previously treated with an antiarrhythmic drug.

This one-of-a-kind event will offer attendees an opportunity to learn more about the heart rhythm disorders, AFib and SCA, and sit down, one-on-one, with medical professionals for free cardiovascular risk assessments.

Current data suggests that a single ablation procedure of the pulmonary veins for treating AFib results in success rates between 20 to 40 percent.

In the European Parliament today, Cristian Busoi MEP, along with European heart advocates, announced the launch of their new AFib Task Force.

The approximately 20 percent of strokes associated with Afib tend to be more severe, disabling, and fatal than other kinds of stroke.

During September, which is National Atrial Fibrillation Awareness Month, this leading afib non-profit organization has several campaigns to further spread the word about atrial fibrillation.